As of 2024-12-14, the Intrinsic Value of Sartorius Stedim Biotech SA (DIM.PA) is
113.11 EUR. This DIM.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 194.10 EUR, the upside of Sartorius Stedim Biotech SA is
-41.70%.
The range of the Intrinsic Value is 75.37 - 203.93 EUR
113.11 EUR
Intrinsic Value
DIM.PA Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
75.37 - 203.93 |
113.11 |
-41.7% |
| DCF (Growth 10y) |
124.01 - 306.86 |
177.98 |
-8.3% |
| DCF (EBITDA 5y) |
102.04 - 199.17 |
146.23 |
-24.7% |
| DCF (EBITDA 10y) |
152.33 - 292.82 |
214.14 |
10.3% |
| Fair Value |
43.49 - 43.49 |
43.49 |
-77.59% |
| P/E |
55.60 - 150.02 |
102.58 |
-47.2% |
| EV/EBITDA |
42.44 - 139.78 |
95.98 |
-50.5% |
| EPV |
24.46 - 38.29 |
31.38 |
-83.8% |
| DDM - Stable |
15.34 - 42.86 |
29.10 |
-85.0% |
| DDM - Multi |
68.66 - 144.70 |
92.67 |
-52.3% |
DIM.PA Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
18,888.88 |
| Beta |
1.21 |
| Outstanding shares (mil) |
97.32 |
| Enterprise Value (mil) |
21,353.78 |
| Market risk premium |
5.82% |
| Cost of Equity |
9.29% |
| Cost of Debt |
5.46% |
| WACC |
8.39% |